Breaking News

Sai Life Sciences Expands Capabilities

Plans to double headcount in Manchester and add a GMP Kilo Lab later in 2021.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sai Life Sciences, a contract research, development and manufacturing organization (CRDMO), has unveiled plans to double its headcount and expand its suite of technical capabilities at its Manchester, UK site, a center of excellence for active pharmaceutical ingredient (API) process and analytical development serving an expanding list of global clients.   “We are truly heartened by our customers’ response to our Manchester site,” said Krishna Kanumuri, chief executive officer and man...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters